M40 (TFA)

CAT:
804-HY-P1025A-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
M40 (TFA) - image 1

M40 (TFA)

  • Description:

    M40 TFA is the TFA salt form of M40. M40 TFA is an antagonist or a weak agonist for galanin receptor depending on different subtypes of galanin receptors in the brain, hypothalamus, hippocampus, amygdala and pancreas[1][2][3].
  • UNSPSC:

    12352209
  • Target:

    Neuropeptide Y Receptor
  • Type:

    Peptides
  • Related Pathways:

    GPCR/G Protein; Neuronal Signaling
  • Applications:

    Neuroscience-Neurodegeneration
  • Field of Research:

    Neurological Disease; Cardiovascular Disease
  • Assay Protocol:

    https://www.medchemexpress.com/m40-tfa.html
  • Purity:

    98.33
  • Solubility:

    10 mM in DMSO
  • Smiles:

    OC (C=C1) =CC=C1C[C@@H] (C (N[C@@H] (CC (C) C) C (N[C@@H] (CC (C) C) C (NCC (N2[C@@H] (CCC2) C (N3[C@@H] (CCC3) C (N4[C@@H] (CCC4) C (N[C@@H] (C) C (N[C@@H] (CC (C) C) C (N[C@@H] (C) C (N[C@@H] (CC (C) C) C (N[C@@H] (C) C (N) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) NC (CNC ([C@H] (C) NC ([C@H] (CO) NC ([C@H] (CC (N) =O) NC ([C@H] (CC (C) C) NC ([C@H] ([C@H] (O) C) NC ([C@@H] (NC (CN) =O) CC5=CNC6=CC=CC=C56) =O) =O) =O) =O) =O) =O) =O.O=C (O) C (F) (F) F.[x]
  • Molecular Formula:

    C95H146N22O24.xC2HF3O2
  • Molecular Weight:

    1980.31 (free base)
  • References & Citations:

    [1]Narváez JA, et al., The galanin receptor antagonist M40 blocks the central cardiovascular actions of the galanin N-terminal fragment (1-15) . Eur J Pharmacol. 2000 Jul 7;399 (2-3) :197-203.|[2]McDonald MP, et al., Galanin inhibits performance on rodent memory tasks. Ann N Y Acad Sci. 1998 Dec 21;863:305-22. |[3]Branchek T, et al., Molecular biology and pharmacology of galanin receptors. Ann N Y Acad Sci. 1998 Dec 21;863:94-107.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
  • Scientific Category:

    Peptides
  • Clinical Information:

    No Development Reported